Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - SALIX PHARMACEUTICALS LTD | d306326d8ka.htm |
| EX-99.1 - AUDITED CONSOLIDATED FINANCIAL STATEMENTS - SALIX PHARMACEUTICALS LTD | d306326dex991.htm |
| EX-99.2 - UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS - SALIX PHARMACEUTICALS LTD | d306326dex992.htm |
EXHIBIT 23.1
Consent of Independent Auditors
We consent to the inclusion of our report dated May 25, 2011 with respect to the consolidated financial statements of Oceana Therapeutics, Inc. for the year ended December 31, 2010 and 2009, in this Current Report on Form 8-K/A of Salix Pharmaceuticals, Ltd. filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
MetroPark, New Jersey
February 28, 2012